AntiCancer Defends Validity Of Cancer Imaging Patents
AntiCancer filed a motion for summary judgment Monday in the U.S. District Court for the Southern District of California, arguing that CRI’s invalidity defense is baseless.
“After three ... years of litigation, CRI has effectively admitted it has no bona fide evidence of invalidity,” the motion said. “Its ... admissions are fatal. A trial...
To view the full article, register now.